Nasdaq

Paradigm Biopharma Advances Phase 3 Trials Amid Financial Prudence

Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update. Paradigm Biopharmaceuticals Ltd. has submitted the final Phase 3 protocol for its knee osteoarthritis treatment to the US FDA, marking ...
Nasdaq

Paradigm Biopharma Highlights Investment Risks and Cautions

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Paradigm Biopharmaceuticals Ltd.
Morningstar

Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally

COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Paradigm Health, the technology company rebuilding the clinical research ecosystem, today announced an oversubscribed $78 million Series B ...
HotCopper on MSN

HotCopper trends: Resolution Minerals, scandium hits, Paradigm Biopharma and more

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front of those trends is so important for any ...